Venus Remedies Limited (BOM:526953)
499.80
+23.80 (5.00%)
At close: Jul 15, 2025
Venus Remedies Revenue
In the fiscal year ending March 31, 2025, Venus Remedies had annual revenue of 6.48B INR with 7.72% growth. Venus Remedies had revenue of 1.95B in the quarter ending March 31, 2025, a decrease of -0.10%.
Revenue
6.48B
Revenue Growth
+7.72%
P/S Ratio
1.03
Revenue / Employee
5.46M
Employees
1,187
Market Cap
6.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.48B | 464.40M | 7.72% |
Mar 31, 2024 | 6.01B | 459.40M | 8.27% |
Mar 31, 2023 | 5.56B | -446.71M | -7.44% |
Mar 31, 2022 | 6.00B | 520.57M | 9.50% |
Mar 31, 2021 | 5.48B | 2.07B | 60.90% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,561.48B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Hindustan Unilever | 631.21B |